id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
DEA-2015-0010-0001,DEA,DEA-2015-0010,Schedules of Controlled Substances: Removal of [123I]Ioflupane From Schedule II,Proposed Rule,,2015-06-03T04:00:00Z,2015,6,2015-06-03T04:00:00Z,2015-07-07T03:59:59Z,2015-07-04T01:30:24Z,2015-13455,0,0,0900006481b17aa2
DEA-2015-0010-0002,DEA,DEA-2015-0010,"DHHS Basis for the recommendation to remove FDA approved products containing [123I]ioflupane from schedule IIof the CSA dated Nov 2, 2010",Supporting & Related Material,,2015-06-03T04:00:00Z,2015,6,,,2015-06-03T15:52:28Z,,0,0,0900006481b17d70
DEA-2015-0010-0004,DEA,DEA-2015-0010,DEA 8-factor analysis for [123I]ioflupane April 2015,Supporting & Related Material,,2015-06-03T04:00:00Z,2015,6,,,2015-06-03T16:01:33Z,,0,0,0900006481b1821b
DEA-2015-0010-0003,DEA,DEA-2015-0010,"DHHS Basis for the recommendation to remove FDA approved products containing [123I]ioflupane from schedule IIof the CSA dated Nov 2, 2010",Supporting & Related Material,,2015-06-03T00:00:00Z,2015,6,,,2015-06-03T16:00:30Z,,0,1,0900006481b1821a